Christopher P. Leamon

Insider Reports History

Location
Boston, MA
Signature
/s/ Maria Stahl as Attorney-in-Fact for Christopher Leamon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher P. Leamon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fusion Pharmaceuticals Inc. Chief Scientific Officer Common Stock 0 $0 $2.03 04 Jun 2024 Direct
Fusion Pharmaceuticals Inc. Chief Scientific Officer Restricted Stock Units 0 $0 $2.03 04 Jun 2024 Direct
Fusion Pharmaceuticals Inc. Chief Scientific Officer Stock Option (Right to Buy) 0 04 Jun 2024 Direct

Insider Reports Filed by Christopher P. Leamon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024068879-leamon-christopher-p-2024-06-04 Fusion Pharmaceuticals Inc. 04 Jun 2024 5 $0 4 Chief Scientific Officer 04 Jun 2024, 17:20
/report/000095017024002301-leamon-christopher-p-2023-08-31 Fusion Pharmaceuticals Inc. 31 Aug 2023 3 $0 4 Chief Scientific Officer 05 Jan 2024, 08:54
/report/000120919123002497-leamon-christopher-p-2023-01-05 Fusion Pharmaceuticals Inc. 05 Jan 2023 1 $0 4 Chief Scientific Officer 09 Jan 2023, 05:44
/report/000120919121062419-leamon-christopher-p-2021-11-01 Fusion Pharmaceuticals Inc. 01 Nov 2021 1 $0 4 Chief Scientific Officer 02 Nov 2021, 16:37
/report/000120919121062399-leamon-christopher-p-2021-11-01 Fusion Pharmaceuticals Inc. 01 Nov 2021 0 $0 3 Chief Scientific Officer 02 Nov 2021, 16:26